Skip to main content
OpenTrials

Clinical trial condition

Unresectable Hepatocellular Carcinoma

Explore clinical trials studying Unresectable Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

61 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Hepatocellular Carcinoma trial results

Terminated

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

NCT05199285

Conditions
Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +19 more
Locations
  • University of Alabama- Birmingham Birmingham, Alabama, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions